Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to compare the pharmacokinetics and safety following administration of DWJ1558 and co-administration of DWC202310 and DWC202311 in healthy volunteers.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention: DWJ1558 | Experimental |
| |
| Intervention: DWC202310 and DWC202311 | Experimental |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| DWJ1558 | Drug | DWJ1558 |
| |
| DWC202310 and DWC202311 |
| Measure | Description | Time Frame |
|---|---|---|
| Cmax,ss of DWJ1558 | Maximum plasma concentration at steady-state(Cmax,ss) of DWJ1558 | At pre-dose (0 hour), and post-dose 1 to 72 hour. |
| AUCt of DWJ1558 | Area under the curve from the time of dosing to the last measurable concentration(AUCt) of DWJ1558 | At pre-dose (0 hour), and post-dose 1 to 72 hour. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| H Plus YANGJI Hospital | Seoul | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
Co-administration of DWC202310 and DWC202311 |
|